These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8381245)

  • 1. Immunolocalization of ras oncogene p21 in human liver diseases.
    Radosevich JA; Gould KA; Koukoulis GK; Haines GK; Rosen ST; Lee I; Gould VE
    Ultrastruct Pathol; 1993; 17(1):1-8. PubMed ID: 8381245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWP.
    Radosevich JA; Combs SG; Ma Y; Lee I; Gould VE; Thor A; Schlom J; Carney WP; Rosen ST
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):337-44. PubMed ID: 2565631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ras oncogene p21 expression in hepatocellular carcinoma.
    Jagirdar J; Nonomura A; Patil J; Thor A; Paronetto F
    J Exp Pathol; 1989; 4(1):37-46. PubMed ID: 2550600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
    Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5.
    Lanza G
    Histopathology; 1988 Jun; 12(6):595-609. PubMed ID: 3047043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
    Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
    Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
    Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
    Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM; Perantoni AO; Santos E
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras p21 in breast tissue: associations with pathology and cellular localisation.
    Going JJ; Anderson TJ; Wyllie AH
    Br J Cancer; 1992 Jan; 65(1):45-50. PubMed ID: 1733441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
    Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
    Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver.
    Brunt EM; Swanson PE
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S53-61. PubMed ID: 1374219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of normal and mutated ras oncogene p21 expression in human pulmonary and pleural neoplasms.
    Radosevich JA; Gould VE; Ma Y; Lee I; Thor A; Carney WP; Warren WH; Schlom J; Rosen ST
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(6):377-83. PubMed ID: 2567085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
    Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
    Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
    Gui K
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Hashimoto T; Terahata S; Matsubara F; Michigishi T; Noguchi M
    Cancer; 1988 Mar; 61(5):873-80. PubMed ID: 3276392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of ras p21 oncoprotein in breast cancer imprints.
    Agnantis NJ; Apostolikas NA; Zolotas VG; Spandidos DA
    Acta Cytol; 1994; 38(3):335-40. PubMed ID: 8191822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas.
    Agnantis NJ; Apostolikas N; Sficas C; Zolota V; Spandidos DA
    Hepatogastroenterology; 1991 Jun; 38(3):239-42. PubMed ID: 1937363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-myc, ras p21 and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands.
    Deguchi H; Hamano H; Hayashi Y
    Acta Pathol Jpn; 1993; 43(7-8):413-22. PubMed ID: 8396843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of ras P21 oncoprotein in human skin lesions.
    Zioga C; Malamou-Mitsis VD; Kamina S; Agnantis NJ
    Anticancer Res; 1995; 15(3):1015-22. PubMed ID: 7645920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.